Qube Research & Technologies LTD Finch Therapeutics Group, Inc. Transaction History

Qube Research & Technologies LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.91 - $5.11 $71,875 - $192,294	-37,631 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$5.02 - $10.47 $65,902 - $137,450	13,128 Added 53.58%	37,631 $189,000
Q4 2021 Feb 01, 2022	BUY	$8.95 - $16.88 $219,301 - $413,610	24,503 New	24,503 $244,000

Ticker FNCH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,688,400
Market Cap $65.3M
Description
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides diffi...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.